The Ulixertinib Expanded Access Program for patients with MAPK mutation ... youtu.be/NhOFjKW0_TQ via YouTube

#ExpandedAccess to new medicines is finally back in focus, tomorrow (Thursday) 2pm Eastern with some very heavy hitters on the broadcast. Sign up here! pheedloop.com/axsthursdays/s…

Wow, thank you so much everyone! Our #ExpandedAccess education center, Ax-S Pharma, just hit 500 subscribers on YouTube! tinyurl.com/1k2bk9n6 #500subs

And we don't forget our roots in #ALS I AM ALS, No More Excuses ALS Watchdogs!, Scott Smith. Moving forward with #ExpandedAccess where it's needed most.

We have just made this FREE. Next Thursday and the whole series on Expanding Access to new medicines. Learn more and sign up here: axspharma.com/axs-thursdays/… #ExpandedAccess #ClinicalTrials #RealWorldEvidence

Ding, ding, ding In collaboration with Dr. Silverman, we identified the first compound that improves the health of UMNs that become diseased due to mSOD1 toxicity & TDP43 pathology. This is good news for #ALS, #HSP, #PLS, and ALS/FTLD patients. Please RT & share the excitement

Here is the "top-of-the-league" on Decentralized #clinicaltrials . Tomorrow (Thursday) at 12pm-1:30pm Eastern. pheedloop.com/axsthursdays/s…

Looking forward to hearing Mika Newton from xCures present the digital precision-oncology platform tomorrow at #AxSThursdays Join here: pheedloop.com/axsthursdays/s…

The full video replays of the 2021 Ax-S Thursdays sessions on Integrating Research and Healthcare are now available on our video page in the "free/signup" section for 2 weeks. axspharma.com/video-resource…

The principals of Parallel Track were rolled into the Expanded Access regulations now in place, applying to all diseases. What's needed is a public reminder that large-cohort #ExpandedAccess was created for treatment use in parallel with research (not just post-research).

The principals of Parallel Track were rolled into the Expanded Access regs now in place, applying to all diseases. What's needed is a public reminder that large-cohort #ExpandedAccess was created for treatment use in parallel with research (not just post-research). Just ask FDA

For #ExpandedAccess there is this: axspharma.com Fact Check ALS, Phil Green, David Taylor Angelina Fanous I AM ALS Rony Podolsky

“#MedAffairsTalk - Expanded Access Programs” with Luca Dezzani, Abby Fraser, Bora Erdemli, PhD, Marieke Jonkman, Amy C. Cavers, and Pharma Medical Affairs. Friday, Jun 4 at 1:00 PM EDT on @clubhouse! clubhouse.com/event/M65keG9B

#ExpandedAccess for patients who cannot get into the research trial was created by FDA 33 years ago as an integral part of the drug development process. But don't take our word for it. axspharma.com/videos/ea3-tra…

Just a few days left of Early Bird registration for the big annual #ExpandedAccess Summit, the global leadership event on pre-market access to medicines. axspharma.com/expanded-acces… #ALS #Cancer #healthcareinnovation

Follow Expanded Access Summit now for real time fact checking on #ExpandedAccess to medicines in during Congressional Hearing on #ALS right now, 11am - 1pm Eastern energycommerce.house.gov/committee-acti…

Amtrak: Protect people by designating some "mask-required" cars on each train - Sign the Petition! chng.it/wRq59Mhk via Change.org

Who decides when a pandemic is over? What we are seeing is a struggle for health equity. Those who are most vulnerable— who, when the next variant strikes, are at highest risk of ending up dead or disabled— are demanding more be done to stop transmission. Stand with them.

We are literally allowing mass casualty medicine to play out rather than lift a damn finger to slow disease spread. Amazing.